Literature DB >> 16301682

Staphylococcal protein a deletes B-1a and marginal zone B lymphocytes expressing human immunoglobulins: an immune evasion mechanism.

Muriel Viau1, Nancy S Longo, Peter E Lipsky, Moncef Zouali.   

Abstract

Protein A (SpA) of Staphylococcus aureus is endowed with the capacity to interact with the H chain variable region (V(H)) of human Abs and to target >40% of B lymphocytes. To investigate whether this property represents a virulence factor and to determine the in vivo consequences of the confrontation of SpA with B lymphocytes, we used transgenic mice expressing fully human Abs. We found that administration of soluble SpA reduces B-1a lymphocytes of the peritoneal cavity and marginal zone B lymphocytes of the spleen, resulting in a markedly deficient type 2 humoral response. Single-cell PCR analysis and sequencing of the Ab V(H) gene repertoire revealed a significant reduction of V(H)3+ marginal zone B cells. Since the two B lymphocyte subsets targeted are involved in innate immune functions, our data suggest that crippling of humoral immunity by S. aureus represents an immune evasion mechanism that may aggravate recurrent infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301682     DOI: 10.4049/jimmunol.175.11.7719

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Corruption of human follicular B-lymphocyte trafficking by a B-cell superantigen.

Authors:  Gwenoline Borhis; Muriel Viau; Gamal Badr; Yolande Richard; Moncef Zouali
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 2.  Recurrent infections and immune evasion strategies of Staphylococcus aureus.

Authors:  Hwan Keun Kim; Vilasack Thammavongsa; Olaf Schneewind; Dominique Missiakas
Journal:  Curr Opin Microbiol       Date:  2011-11-14       Impact factor: 7.934

Review 3.  Mapping the pathways to staphylococcal pathogenesis by comparative secretomics.

Authors:  M J J B Sibbald; A K Ziebandt; S Engelmann; M Hecker; A de Jong; H J M Harmsen; G C Raangs; I Stokroos; J P Arends; J Y F Dubois; J M van Dijl
Journal:  Microbiol Mol Biol Rev       Date:  2006-09       Impact factor: 11.056

4.  Host-Pathogen Interface: Progress in Understanding the Pathogenesis of Infection Due to Multidrug-Resistant Bacteria in the Intensive Care Unit.

Authors:  Danielle Ahn; Alice Prince
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

5.  HTJoinSolver: Human immunoglobulin VDJ partitioning using approximate dynamic programming constrained by conserved motifs.

Authors:  Daniel E Russ; Kwan-Yuet Ho; Nancy S Longo
Journal:  BMC Bioinformatics       Date:  2015-05-23       Impact factor: 3.169

Review 6.  Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond.

Authors:  Olivier Garraud; Gwenoline Borhis; Gamal Badr; Séverine Degrelle; Bruno Pozzetto; Fabrice Cognasse; Yolande Richard
Journal:  BMC Immunol       Date:  2012-11-29       Impact factor: 3.615

7.  Marginal zone B-cells, a gatekeeper of innate immunity.

Authors:  Moncef Zouali; Yolande Richard
Journal:  Front Immunol       Date:  2011-12-13       Impact factor: 7.561

8.  Characterization of Virulence Factors of Staphylococcus aureus: Novel Function of Known Virulence Factors That Are Implicated in Activation of Airway Epithelial Proinflammatory Response.

Authors:  Justyna Bien; Olga Sokolova; Przemyslaw Bozko
Journal:  J Pathog       Date:  2011-09-14

9.  Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections.

Authors:  Monica I Ardura; Romain Banchereau; Asuncion Mejias; Tiziana Di Pucchio; Casey Glaser; Florence Allantaz; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Octavio Ramilo
Journal:  PLoS One       Date:  2009-05-08       Impact factor: 3.240

10.  Looking through Staphylococcus pseudintermedius infections: Could SpA be considered a possible vaccine target?

Authors:  Erika Grandolfo
Journal:  Virulence       Date:  2018-12-31       Impact factor: 5.882

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.